Cas No.: | 1610546-52-5 |
Chemical Name: | (3R,6R,9R,12S,15S)-9-benzhydryl-3,12-diisobutyl-15-isopropyl-1-methyl-6-(thiazol-4-ylmethyl)-1,4,7,10,13-pentaazacyclopentadecane-2,5,8,11,14-pentaone |
Synonyms: | SM 253;SM-253 |
SMILES: | N(C)1[C@H](C(C)C)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](C(C2=CC=CC=C2)C2=CC=CC=C2)C(=O)N[C@@H](CC2=CSC=N2)C(=O)N[C@@H](CC(C)C)C1=O |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | SM253 (SM 253, SM-253) is a novel potent Hsp90 inhibitor that does not induce heat shock response; demonstrates cytotoxicity to both HCT-116 and MiaPaCa-2 cells lines with IC50 of 5 and 5.5 uM, respectively; also induces apoptosis and significantly increases caspase 3/7 activity compared to 17-AAG (2-fold); binds to the N-middle linker region of Hsp90, resulting in reduced client protein activation and preventing C-terminal co-chaperones and client proteins from binding to Hsp90; exhibits antiproliferative and pro-apoptotic activity in multiple prostate cancer cell lines (LNCaP, 22Rv1, and PC-3) at low micromolar concentrations. |